Hologic Shareholders Approve $18.3 Billion Buyout by Blackstone and TPG

Hologic is set to be taken private after shareholders and regulators approved its acquisition by funds managed by Blackstone and TPG in a transaction valued at up to $18.3 billion including debt.

The agreement, announced on October 21, 2025, outlined that Hologic shareholders would receive $76 per share in cash and a non-tradable contingent value right tied to future revenue milestones. The deal also involves minority investments from a subsidiary of the Abu Dhabi Investment Authority and an affiliate of Singapore’s GIC.

On February 5, 2026, Hologic shareholders voted to approve the merger, with approximately 99.8% of the 179 million shares represented voting in favor. The board of directors had previously given unanimous approval and recommended that shareholders support the agreement.

China’s State Administration for Market Regulation granted regulatory approval for the acquisition on February 9, 2026, removing a key obstacle for the transaction. The deal remains subject to additional closing conditions and regulatory clearances in other jurisdictions.

What the numbers show

• The acquisition is valued at up to $18.3 billion including debt
• Shareholders will receive $76 per share in cash and up to $3 per share in contingent value rights
• About 99.8% of 179 million shares voted in favor of the merger
• The agreement was announced on October 21, 2025
• China’s regulatory approval was granted on February 9, 2026

The contingent value right included in the offer allows for up to $3 per share, payable in two installments of up to $1.50 each, depending on whether Hologic achieves certain revenue milestones in fiscal years 2026 and 2027. This structure provides shareholders with additional potential compensation based on future company performance.

The transaction is expected to close in March or April 2026, according to information published following the regulatory approval in China. The completion remains contingent on meeting all customary closing conditions and securing any remaining regulatory and shareholder approvals.

The involvement of international investors, including entities from Abu Dhabi and Singapore, was confirmed as part of the overall financing structure. These minority investments are intended to support the buyout led by Blackstone and TPG.

Hologic’s board of directors had recommended the transaction to shareholders, and the overwhelming approval at the special meeting advanced the process toward completion. The company will transition to private ownership upon closing of the deal.

* This article is based on publicly available information at the time of writing.